Find News

Filter articles

Applied Filters

Showing 11 to 20 of 128 results

South Korean global licensing spikes n 2018

South Korea22-01-2019

South Korean pharmaceutical companies entered into 11 out-licensing deals with overseas partners in 2018, according to the country’s Ministry of Health and Welfare.

Sun Pharma buys Japanese company for $1m

India, Japan26-11-2018Mergers & acquisitions

India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma.

Scientists want CRISPR regulation amid reports of foetus gene-editing


Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.

Indian court rules in Sanofi’s favour in trademark suit


The Delhi High Court has ruled against a company for its ‘near identical’ imitation of pharmaceutical company Sanofi’s name and trademarks.

LSPN Europe 2018: Chinese filings impressive statement, says EPO director

China, EPO15-11-2018

Last year, for the first time in European Patent Office history, a Chinese company filed the most European patent applications, making an “impressive statement” on what companies in the country are doing, according to Peter Albrecht. 

Australia approves Arrow and Apotex merger


The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex.

Bombay court finds company liable for infringing Glenmark TM


The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks.

Finnegan partner joins Quinn Emanuel in Tokyo


York Faulkner, an IP partner from Finnegan, Henderson, Farabow, Garrett & Dunner, has joined Quinn Emanuel Urquhart & Sullivan in Tokyo.

Astellas boosts ocular pipeline with gene therapy acquisition

Japan, UK15-08-2018

Japan-based Astellas Pharma has acquired Quethera, a UK-headquartered gene therapy company focused on developing treatments for ocular disorders.

Samsung to make $22bn investment in new technology

South Korea10-08-2018

South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence.

Showing 11 to 20 of 128 results